These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5791403)

  • 21. Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease.
    Asfaha S; Almansori M; Qarni U; Gutfreund KS
    J Clin Apher; 2007; 22(5):295-8. PubMed ID: 17880018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemolytic anemias in kidney diseases].
    Luciak M
    Przegl Lek; 1995; 52(3):80-3. PubMed ID: 7644677
    [No Abstract]   [Full Text] [Related]  

  • 24. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemolysis and consumption coagulopathy due to overheated dialysate.
    Tielemans CL; Herbaut CR; Geurts JO; Dratwa M
    Nephron; 1982; 30(2):190-1. PubMed ID: 7099328
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemolytic anemia associated with copper sulfate poisoning.
    ROBERTS RH
    Miss Doct; 1956 Mar; 33(10):292-4. PubMed ID: 13296973
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of hemolysis in regular hemodialysis patients by measuring carbon monoxide production rate.
    Lerner R; Werner B; Asaba H; Ternstedt B; Elmqvist E
    Clin Nephrol; 1983 Nov; 20(5):239-43. PubMed ID: 6652977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood folates in chronic uremic patients in dialysis treatment].
    Chelazzi G; Bernasconi G; Gastaldi L; Martegani M; Fachinetti A; Giuliani F
    Minerva Med; 1980 Oct; 71(42):3073-86. PubMed ID: 7022266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity and mortality of dialysis.
    NIH Consens Statement; 1993 Nov 1-3; 11(2):1-33. PubMed ID: 8004133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current trends in dialysis therapy.
    Jacobs C
    Kidney Int Suppl; 1997 Nov; 62():S93-5. PubMed ID: 9350692
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential hepatotoxicity of copper in recurrent hemodialysis.
    Blomfield J; Dixon SR; McCredie DA
    Arch Intern Med; 1971 Oct; 128(4):555-60. PubMed ID: 4939231
    [No Abstract]   [Full Text] [Related]  

  • 32. Copper, pH, and hemodialysis.
    Klein WJ
    Ann Intern Med; 1971 Jan; 74(1):147-8. PubMed ID: 5539273
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complications of hemodialysis and their management in uremic children].
    Túri S; Kiss E; Bodrogi T; Tekulics P
    Orv Hetil; 1983 Apr; 124(15):873-7. PubMed ID: 6304593
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prophylactic and conservative treatment of arteriovenous shunts in chronic kidney disease patients treated with periodic hemodialysis].
    Ancona G
    Chir Patol Sper; 1966; 14(7):246-65. PubMed ID: 5990179
    [No Abstract]   [Full Text] [Related]  

  • 35. Some medical problems of chronic hemodialysis.
    Gral T; Sokol A; Rubini ME
    Isr J Med Sci; 1967; 3(1):14-27. PubMed ID: 6067675
    [No Abstract]   [Full Text] [Related]  

  • 36. [Proposal for a differentiated hemolytic treatment in chronic uremia].
    Vercellone A; Piccoli G; Martini PF; Mangiarotti C; Giachino G; Fruttero B; Quarello F
    G Clin Med; 1973 Oct; 54(10):644-65. PubMed ID: 4789298
    [No Abstract]   [Full Text] [Related]  

  • 37. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
    Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V
    Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of malignancy and blood-membrane interactions in uraemic patients.
    Akizawa T; Kinugasa E; Koshikawa S
    Nephrol Dial Transplant; 1994; 9 Suppl 2():162-4. PubMed ID: 8065609
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemolysis in dialized patients caused by chloramines.
    Kjellstrand CM; Eaton JW; Yawata Y; Swofford H; Kolpin CF; Buselmeier TJ; von Hartitzsch B; Jacob HS
    Nephron; 1974; 13(6):427-33. PubMed ID: 4431554
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute pericarditis treatment during maintenance hemodialysis (author's transl)].
    Di Marco V; Ginardi V; Mazzone O; Trovato GM
    G Ital Cardiol; 1980; 10(1):79-83. PubMed ID: 7461311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.